The Legal 500: Pharmaceutical Advertising Country Comparative Guide 2023

The latest edition of the Legal 500: Pharmaceutical Advertising Comparative Guide is now online. The aim of this guide is to provide its readers with a pragmatic overview of the law and practice of pharmaceutical advertising law across a variety of jurisdictions.

Each chapter of this guide provides information about the current issues affecting pharmaceutical advertising in a particular country and addresses topics such as self-regulation, press releases, gifts, samples, grants or donations, anti-bribery rules, regulatory authorities and courts, as well as insight and opinion on the most common issues in their respective country.

The Q&A template for each chapter has been provided by Sally Shorthose.

We have written the UK chapter of the guide which provides an overview of the pharmaceutical advertising laws and regulations applicable in the UK.

Download the UK chapter here 

Latest insights

More Insights
Curiosity line blue background

Five Key Considerations for M&A in the Retail and Consumer Sector

Jun 28 2024

Read More
City skyline at dusk

Are you ready for Hong Kong’s Cybersecurity law?

Jun 28 2024

Read More
Curiosity line yellow background

Economic Crime and Corporate Transparency Act 2023 – Implications of the UK Act for Australian companies

Jun 28 2024

Read More

Related capabilities